Subject:

Tyrosine kinase   New Search


View on DBpedia    View on Wikipedia
Top related subjects:
RELATED SUBJECTS:
The publications listed also have these subjects

Growth factor  12 times
Chemotherapy  11 times
Kinase  9 times
Gene  8 times
Cell surface receptor  7 times
Western blot  6 times
Phosphorylation  6 times
Non-small-cell lung carcinoma  6 times
Mitogen-activated protein kinase  6 times
Imatinib  6 times
Estrogen receptor  6 times
Enzyme inhibitor  6 times
Tyrosine  5 times
Multivariate analysis  5 times
Metastasis  5 times
Immunohistochemistry  5 times
Antibody  5 times
Acute myeloid leukemia  5 times
Targeted therapy  4 times
Protein kinase B  4 times
Protein  4 times
Phosphoinositide 3-kinase  4 times
Neu!  4 times
Mouse  4 times
Colorectal cancer  4 times
Breast cancer  4 times
Stomach cancer  3 times
Sorafenib  3 times
Progression-free survival  3 times
Performance status  3 times
Myeloid tissue  3 times
MAPK3  3 times
Immunotherapy  3 times
Flow cytometry  3 times
Epigenetics  3 times
Chronic myelogenous leukemia  3 times
CD135  3 times
Apoptosis  3 times
Angiogenesis  3 times
Xenotransplantation  2 times
Trastuzumab  2 times
T cell  2 times
Sunitinib  2 times
Small interfering RNA  2 times
Receptor tyrosine kinase  2 times
Real-time polymerase chain reaction  2 times
Radiation therapy  2 times
Programmed cell death protein 1  2 times
Pre-eclampsia  2 times
Placebo  2 times
P53  2 times
Oxidative stress  2 times
Neoadjuvant therapy  2 times
Monoclonal antibody  2 times
Molecular biology  2 times
Messenger RNA  2 times
Lymphoma  2 times
Library  2 times
Leukemia  2 times
Immune checkpoint  2 times
Hypertension  2 times
Hormone  2 times
Histone deacetylase  2 times
Hematopoietic stem cell transplantation  2 times
Hematopoietic stem cell  2 times
Haematopoiesis  2 times
Glucose  2 times
Extracellular signal–regulated kinases  2 times
Erlotinib  2 times
Dasatinib  2 times
DNA  2 times
Cytotoxic T cell  2 times
Crizotinib  2 times
Confidence interval  2 times
Cell cycle  2 times
Caspase  2 times
Carcinoma  2 times
Adenocarcinoma  2 times
WT1  1 time
Vitamin K2  1 time
Vimentin  1 time
Vasoconstriction  1 time
Umbilical vein  1 time
Tyrosine-kinase inhibitor  1 time
Tumor hypoxia  1 time
Triple-negative breast cancer  1 time
Transmission electron microscopy  1 time
Transfection  1 time
Transcription factor  1 time
Toll-like receptor  1 time
Thyroid hormones  1 time
Thyroid cancer  1 time
Threonine  1 time
TNBC  1 time
T-cell receptor  1 time
Systems biology  1 time
Systemic scleroderma  1 time
Synovial fluid  1 time
Syndrome  1 time
Splenomegaly  1 time
Spleen  1 time
Sirolimus  1 time
Signal transduction  1 time
Serotonin  1 time
Serine  1 time
Sequence homology  1 time
Sepsis  1 time
Salvage therapy  1 time
Salivary gland  1 time
STAT3  1 time
S100A8  1 time
Reporter gene  1 time
Renal cell carcinoma  1 time
Receiver operating characteristic  1 time
RNA  1 time
QT interval  1 time
Purine  1 time
Proteolysis  1 time
Proteasome  1 time
Prostate cancer  1 time
Prostaglandin-endoperoxide synthase 2  1 time
Positron  1 time
Polymerase chain reaction  1 time
Polymerase  1 time
Polish language  1 time
Placenta  1 time
Phosphatidylinositol  1 time
Philadelphia  1 time
Phagocytosis  1 time
P38 mitogen-activated protein kinases  1 time
Oncogene  1 time
Nucleoside  1 time
Nivolumab  1 time
Neutropenia  1 time
Nephrectomy  1 time
Myeloproliferative neoplasm  1 time
Myc  1 time
Mutation  1 time
Mitsubishi Ki-67  1 time
Middle cerebral artery  1 time
Microtubule  1 time
Microorganism  1 time
MicroRNA  1 time
Metabolism  1 time
Metabolic pathway  1 time
Mesothelioma  1 time
Melanoma  1 time
Mechanistic target of rapamycin  1 time
Mass spectrometry  1 time
Macrophage  1 time
MTT assay  1 time
MEDLINE  1 time
MCL1  1 time
MAPK/ERK pathway  1 time
MAP2K1  1 time
Lymph node  1 time
Luciferase  1 time
List of breast cancer cell lines  1 time
Lipopolysaccharide  1 time
Lipase  1 time
Ligand  1 time
Leukocytosis  1 time
KRAS  1 time
Janus  1 time
Ipilimumab  1 time
Iodine  1 time
Intron  1 time
Internal carotid artery  1 time
Interferon  1 time
Infarction  1 time
Immunoglobulin G  1 time
Immunocytochemistry  1 time
Immune tolerance  1 time
Immune system  1 time
Hypoalbuminemia  1 time
Hyperlipidemia  1 time
Hepatotoxicity  1 time
Hepatocyte  1 time
Hazard  1 time
Gracilis muscle  1 time
Glioma  1 time
Gene therapy  1 time
Gastrointestinal tract  1 time
Gas chromatography  1 time
Focal adhesion  1 time
Fluorescence microscope  1 time
Fibroblast growth factor  1 time
Fibroblast  1 time
Fatty acid  1 time
Extracellular matrix  1 time
Excipient  1 time
Epiphysis  1 time
Endothelium  1 time
Endoplasmic reticulum  1 time
Embase  1 time
Ejection fraction  1 time
ELISA  1 time
Disease  1 time
Diarrhea  1 time
Diabetes mellitus type 2  1 time
Descending thoracic aorta  1 time
DNA sequencing  1 time
DNA polymerase  1 time
Cytoskeleton  1 time
Cytokine  1 time
Cyclic adenosine monophosphate  1 time
Critical Role  1 time
ClinicalTrials.gov  1 time
Cirrhosis  1 time
Chronic kidney disease  1 time
Chorioallantoic membrane  1 time
Chemokine receptor  1 time
Cell potency  1 time
Cardiovascular disease  1 time
Cardiomyopathy  1 time
Cardiac arrhythmia  1 time
Carbon  1 time
Cancer immunotherapy  1 time
Calcium phosphate  1 time
Cadherin  1 time
CXCR4  1 time
CTLA-4  1 time
CT scan  1 time
CD34  1 time
C-Jun N-terminal kinases  1 time
Brain ischemia  1 time
Blood plasma  1 time
Biopsy  1 time
Biochemical cascade  1 time
Beta cell  1 time
BRAF (gene)  1 time
B-cell chronic lymphocytic leukemia  1 time
Autophagy  1 time
Autocrine signalling  1 time
Atherosclerosis  1 time
Aromatase  1 time
Antioxidant  1 time
Ant colony  1 time
Androgen receptor  1 time
Anaplastic lymphoma kinase  1 time
Amylase  1 time
Amplifier  1 time
Alizarin  1 time
Albumin  1 time
Adjuvant  1 time
Adenosine diphosphate ribose  1 time
Acute lymphoblastic leukemia  1 time
Acute liver failure  1 time
Actin  1 time
Acetylcholine  1 time

Publications tagged with this subject: 50

Note: Top 50 publications shown only. Open an item panel to view more info




Questions?

Drop us a message.